Graphene-based 3D-Printed nanocomposite bioelectronics for monitoring breast cancer cell adhesion
Biosensors and Bioelectronics · 2023-04 · 226 · 115113
DOI: 10.1016/j.bios.2023.115113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023-04. Verfasst von Jose Muñoz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Future Energy and Innovation Laboratory, Central European Institute of Technology, Brno University of Technology, Purkyňova 123, 61200, Brno, Czech R…. Hauptthemen laut MEDLINE: Graphite, Breast Neoplasms, Biosensing Techniques, Nanocomposites. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: European Regional Development Fund, Grantová Agentura České Republiky.
Abstract (Originalsprache)
This work examines the suitability of graphene-based 3D-printed nanocomposite bioelectronics as innovative systems to in situ monitor and evaluate both breast cancer cell adhesion and the chemosensitivity of anti-cancer drugs. With this aim, 3D-printed nanocomposite graphene electrodes (3D-nGEs) -made of a commercially available graphene/polylactic acid filament- have been covalently biofunctionalized with an extracellular matrix protein (i.e., fibronectin) by exploiting the carbon reactivity of 3D-nGEs. The specificity and selectivity of the developed electrochemical system to monitor breast cancer cell adhesion has been tested via electrochemical impedance spectroscopy (EIS). Importantly, the resulting 3D-printed bioelectronic system displayed excellent accuracy for the rapid screening of anti-cancer drugs, which exactly corresponded with the results achieved by the standard optical method, while having the advantage of employing a label-free approach. In light of the current state-of-the-art in the field, this proof-of-concept connects electronics to biological systems within 3D printing technology, providing the bases for the sustainable and cost-effective manufacturing of graphene-based 3D-printed nanocomposite bioelectronics to simulate in vivo microenvironments using in situ and real time electronic output signals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Future Energy and Innovation Laboratory, Central European Institute of Technology, Brno University of Technology, Purkyňova 123, 61200, Brno, Czech Republic.
- Center for Translational Medicine (CTM), St. Anne's University Hospital, International Clinical Research Centre (FNUSA-ICRC), 62500, Brno, Czech Republic.
- Center for Translational Medicine (CTM), St. Anne's University Hospital, International Clinical Research Centre (FNUSA-ICRC), 62500, Brno, Czech Republic; British Heart Foundation Centre of Research Excellence, School o…
- Future Energy and Innovation Laboratory, Central European Institute of Technology, Brno University of Technology, Purkyňova 123, 61200, Brno, Czech Republic; Faculty of Electrical Engineering and Computer Science, VSB -…
Förderung
- European Regional Development Fund
- Grantová Agentura České Republiky
Zitieren
APA
Muñoz, J., Oliver-De La Cruz, J., Forte, G., & Pumera, M. (2023). Graphene-based 3D-Printed nanocomposite bioelectronics for monitoring breast cancer cell adhesion. Biosensors and Bioelectronics, 226, 115113. https://doi.org/10.1016/j.bios.2023.115113
Vancouver
Muñoz J, Oliver-De La Cruz J, Forte G, Pumera M. Graphene-based 3D-Printed nanocomposite bioelectronics for monitoring breast cancer cell adhesion. Biosensors and Bioelectronics. 2023;226:115113. doi:10.1016/j.bios.2023.115113
BibTeX
@article{Muoz2023,
author = {Muñoz, Jose and Oliver-De La Cruz, Jorge and Forte, Giancarlo and Pumera, Martin},
title = {Graphene-based 3D-Printed nanocomposite bioelectronics for monitoring breast cancer cell adhesion},
journal = {Biosensors and Bioelectronics},
year = {2023},
volume = {226},
pages = {115113},
doi = {10.1016/j.bios.2023.115113}
}
EUVIMED